Evotec SE (EVO) Revenue (QoQ) (2009 - 2025)
Powered by 
Analysis
Evotec SE (EVO) Revenue (QoQ) (2009 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -99.85% |
| Sep 30, 2025 | -1.15% |
| Jun 30, 2025 | -7.85% |
| Mar 31, 2025 | 88,892.18% |
| Dec 31, 2024 | -99.88% |
| Sep 30, 2024 | 190.50% |
| Jun 30, 2024 | -198.94% |
| Mar 31, 2024 | 36,228.75% |
| Dec 31, 2022 | -99.70% |
| Sep 30, 2022 | -4.59% |
| Jun 30, 2022 | 99,322.55% |
| Mar 31, 2022 | -99.97% |
| Dec 31, 2021 | 375,399.09% |
| Sep 30, 2021 | 13.12% |
| Jun 30, 2021 | 3.69% |
| Mar 31, 2021 | -99.97% |
| Dec 31, 2020 | 394,960.81% |
| Sep 30, 2010 | -7.11% |
| Jun 30, 2010 | 141,417.33% |
| Mar 31, 2010 | -99.91% |